Cybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights

TORONTO, February 11, 2025--Cybin Inc. (NYSE American:CYBN) (Cboe Canada CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today reported unaudited financial results for its third quarter ended December 31, 2024, and recent business highlights.

Feb 10, 2025 - 23:30
 0  4
Cybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights
TORONTO, February 11, 2025--Cybin Inc. (NYSE American:CYBN) (Cboe Canada CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today reported unaudited financial results for its third quarter ended December 31, 2024, and recent business highlights.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow